Pricing Log in Create free account

IN8bio, Inc. (INAB) vs Alaunos Therapeutics, Inc. (TCRT)

IN8bio, Inc. and Alaunos Therapeutics, Inc. are both Biotechnology companies. IN8bio, Inc. and Alaunos Therapeutics, Inc. are of similar size ($8.2M and $7.6M). Across the 10 metrics below, IN8bio, Inc. leads on 5 and Alaunos Therapeutics, Inc. on 5.

Valuation

Metric INAB TCRT Biotechnology median
P/E n/m n/m 10.60
P/S n/m 312.69 9.40
P/B 0.99 6.71 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 1,408.11 9.02
Earnings yield (231.18%) (107.37%) (32.88%)
Free cash flow yield (80.81%) (30.18%) (23.13%)

Profitability

Metric INAB TCRT Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (111.11%) (185.95%) (51.96%)
Return on assets (90.80%) (128.30%) (46.06%)
Return on invested capital (2,948.56%) (480.35%) 0.00%

Growth

Metric INAB TCRT Biotechnology median
Revenue growth (TTM) — (17.65%) 6.76%
EPS growth (last fiscal year) 74.06% 24.66% 29.88%
Revenue growth, 5-year CAGR — (49.08%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INAB TCRT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.21 0.77 4.97
Net debt to EBITDA 1.56 0.33 1.01

Dividend

Metric INAB TCRT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric INAB TCRT Biotechnology median
Market cap 8.19m 7.60m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack